|
|
|
Generation Bio Co (NASDAQ: GBIO) |
|
Generation Bio Co
GBIO's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Generation Bio Co growth rates, revenue grew
by 114.91 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 146
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.44 %
Generation Bio Co net loss decreased from $-75 millions, to $-15 millions in first quarter of 2025,
• More on GBIO's Growth
|
|
Generation Bio Co
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 2.87 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 1.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.
• More on GBIO's Valuation
|
|
|
|
|
Generation Bio Co
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 2.87 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 1.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.
Generation Bio Co Price to Book Ratio is at 0.52 lower than Industry Avg. of 35.15. and higher than S&P 500 Avg. of 0.01
• More on GBIO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
